Senhwa Biosciences

About:

Senhwa is a drug development company creating innovative therapies for cancer and related diseases.

Website: http://senhwabiosciences.com

Top Investors: WI Harper Group, Morningside Group, H&Q Asia Pacific, China Investment & Development

Description:

Senhwa Biosciences identifies and develops innovative therapies that have the potential to fundamentally change the way patients are treated. Our central philosophy is to unearth validated targets or therapies that could significantly improve treatment, but have not yet been properly exploited. As a value-added development company, Senhwa aims to take innovative therapies that could impact the current standard of care and drive them through to clinical proof-of-concept.

Total Funding Amount:

$17M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Diego, California, United States

Founded Date:

2013-01-01

Founders:

Tai-Sen Soong

Number of Employees:

1-10

Last Funding Date:

2013-12-12

IPO Status:

Private

Industries:

© 2025 bioDAO.ai